Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$365,549
-$19,065 QoQ
Shares Held
39,180
+2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#218
of 639 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aspen Grove Capital, LLC holds $588,647 across 2 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (62.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
39,180 | $365,549 | |
| 2 | VTRS |
Viatris Inc
|
14,049 | $223,098 |
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,549 | 39,180 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $384,614 | 38,423 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $365,051 | 36,108 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $320,623 | 35,744 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $583,073 | 56,227 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $576,106 | 55,987 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $534,115 | 55,987 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $576,990 | 54,536 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $450,120 | 54,494 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $428,014 | 50,414 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $392,192 | 47,654 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $370,993 | 44,537 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $306,783 | 36,609 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $244,208 | 30,001 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $236,304 | 29,538 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||